Maria Diab

2.2k total citations · 1 hit paper
42 papers, 810 citations indexed

About

Maria Diab is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Maria Diab has authored 42 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Maria Diab's work include Cancer Immunotherapy and Biomarkers (10 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Maria Diab is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Maria Diab collaborates with scholars based in United States, Syria and Canada. Maria Diab's co-authors include Asfar S. Azmi, Mohammed Najeeb Al Hallak, Rachel Sexton, Bassel F. El‐Rayes, Mohammad Arabi, Mohamad Bassam Sonbol, Belal Firwana, Rokana Taftaf, Philip A. Philip and Walid L. Shaib and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Maria Diab

34 papers receiving 794 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gastric cancer: a comprehensive review of current and future treatment strategies

2020 481 citations Rachel Sexton, Mohammed Najeeb Al Hallak et al. Cancer and Metastasis Reviews profile →

Peers

Maria Diab

ONCOL

PRM

SURGE

Chang Yang China

Firas Baidoun United States

Çiğdem Erten Türkiye

Kakil Ibrahim Rasul Qatar

Selja Koskensalo Finland

Xiaorong Yang China

Daichi Ishikawa Japan

Sakkaraiappan Ramalingam United States

Giovanni Codacci-Pisanelli Italy

Chang Yang China

Maria Diab

498 ×1.4

250 ×0.9

ONCOL

339 ×1.5

115 ×0.5

PRM

91 ×0.7

SURGE

Citations per year, relative to Maria Diab Maria Diab (= 1×) peers Chang Yang

Countries citing papers authored by Maria Diab

Since Specialization

Citations

This map shows the geographic impact of Maria Diab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Diab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Diab more than expected).

Fields of papers citing papers by Maria Diab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Diab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Diab. The network helps show where Maria Diab may publish in the future.

Co-authorship network of co-authors of Maria Diab

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Diab. A scholar is included among the top collaborators of Maria Diab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Diab. Maria Diab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greene, Emily R., Natalie K. Horvat, Deon B. Doxie, et al.. (2025). High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. Cancer Research.

Diab, Maria, et al.. (2025). Calcinosis Cutis With Selective Fibroblast Growth Factor Receptor Inhibitors: A Case Report and Review of Literature. Cureus. 17(5). e83773–e83773.

Alese, Olatunji B., Natalie K. Horvat, Emily R. Greene, et al.. (2025). XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial. OncoImmunology. 14(1). 2475620–2475620. 5 indexed citations

Yavuz, Betül Gök, Yehia I. Mohamed, Sunyoung S. Lee, et al.. (2024). Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 7(4). 255–262. 3 indexed citations

Alese, Olatunji B., Maria Diab, Olumide B. Gbolahan, et al.. (2023). Nipavect: Phase II study of niraparib and panitumumab in advanced RAS WT colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3579–3579. 3 indexed citations

Akce, Mehmet, Batoul Farran, Jeffrey M. Switchenko, et al.. (2023). Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(10). e007235–e007235. 24 indexed citations

Mohamed, Yehia I., Sunyoung S. Lee, James C. Yao, et al.. (2023). Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology. 101(11). 730–737. 2 indexed citations

Khalil, Lana, Yuan Liu, Nima Kokabi, et al.. (2023). Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. 4(2). 77–88. 3 indexed citations

Zhang, Yining, Katerina Zakka, Renjian Jiang, et al.. (2022). Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study. Journal of Gastrointestinal Oncology. 13(5). 2306–2321. 1 indexed citations

10.

Farran, Batoul, Jeffrey M. Switchenko, Lana Khalil, et al.. (2022). Abstract 3482: Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Cancer Research. 82(12_Supplement). 3482–3482. 1 indexed citations

11.

Diab, Maria, et al.. (2022). Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.. Journal of Clinical Oncology. 40(16_suppl). 4118–4118.

12.

Khalil, Lana, Jeffrey M. Switchenko, Olatunji B. Alese, et al.. (2022). Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer. The Oncologist. 27(9). 740–750. 5 indexed citations

13.

Alese, Olatunji B., Wei Zhou, Renjian Jiang, et al.. (2021). Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival. Frontiers in Oncology. 11. 728076–728076. 20 indexed citations

14.

Jiang, Renjian, Philip A. Philip, Maria Diab, et al.. (2021). High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer. Frontiers in Oncology. 11. 755113–755113. 8 indexed citations

15.

Khan, Husain Yar, Rachel Sexton, Srikant Viswanadha, et al.. (2020). Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Cancers. 12(3). 750–750. 28 indexed citations

16.

Sexton, Rachel, Mohammed Najeeb Al Hallak, Maria Diab, & Asfar S. Azmi. (2020). Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer and Metastasis Reviews. 39(4). 1179–1203. 481 indexed citations breakdown →

17.

Sexton, Rachel, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Maria Diab, & Asfar S. Azmi. (2020). Gastric Cancer Heterogeneity and Clinical Outcomes. Technology in Cancer Research & Treatment. 19. 1079203125–1079203125. 33 indexed citations

18.

Diab, Maria, Asfar S. Azmi, Ramzi M. Mohammad, & Philip A. Philip. (2018). Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges. Expert Opinion on Pharmacotherapy. 20(5). 535–546. 21 indexed citations

19.

Diab, Maria, et al.. (2017). Malignant acrospiroma: a case report in the era of next generation sequencing. BMC Cancer. 17(1). 221–221. 3 indexed citations

20.

Sonbol, Mohamad Bassam, et al.. (2015). The Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis. Nutrition and Cancer. 67(8). 1232–1240. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact